Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) binds to a 45-nucleotide recognition element in lncRNA-0021 that partially overlaps the miR-6361 binding site, creating a molecular gate. At baseline, hnRNPA2B1 binding masks the seed match; under inflammatory conditions in AD, hnRNPA2B1 phosphorylation releases the constraint and exposes the miR-6361 target. Therapeutic stabilization of the hnRNPA2B1-lncRNA-0021 complex using small molecule allosteric modulators could prevent aberrant miR-6361 release and maintain neuronal autophagy.
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
7 citations7 with PMIDValidation: 0%3 supporting / 4 opposing
✓For(3)
No supporting evidence
No opposing evidence
(4)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
6
1
MECH 6CLIN 1GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
The regulatory impact of RNA-binding proteins on m…
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.